LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
54
Avg Return
Past Year
Past Year
24%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73.8%
Neutral
21.3%
Negative
4.9%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $46 |
21%
upside
| 6 | +11% |
0
%
| 22 Dec ‘25 16 days ago |
|
|
|
Outperform
Maintained
| $30 |
77%
upside
| 3 | +9.3% |
0
%
| 11 Dec ‘25 27 days ago |
|
|
|
Neutral
Maintained
| $33 |
32%
downside
| 2 | – |
–
| 11 Dec ‘25 27 days ago |
|
|
|
Outperform
Maintained
| $47 |
54%
upside
| 1 | -3.9% |
0
%
| 10 Dec ‘25 28 days ago |
|
|
|
Underperform
Maintained
| $83 |
72%
downside
| 3 | -126% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $30 |
20%
upside
| 3 | +18% |
0
%
| 13 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $36 |
11%
downside
| 2 | +90% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $32 |
30%
upside
| 2 | +36% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $32 |
9%
downside
| 2 | +63% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $13 |
2%
downside
| 2 | +79% |
0
%
| 15 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $11 |
222%
upside
| 2 | +20% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $8 |
12%
upside
| 2 | +64% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| $48 | – | 3 | +55% |
0
%
| 9 Sep ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $18 |
36%
upside
| 3 | +17% |
0
%
| 14 Aug ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $14 |
150%
upside
| 2 | +63% |
0
%
| 13 Aug ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $43 |
2%
upside
| 1 | +23% |
0
%
| 12 Aug ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $32 |
12%
downside
| 3 | +31% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $5 |
107%
upside
| 3 | +33% |
0
%
| 6 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $14 |
140%
upside
| 1 | +33% |
0
%
| 5 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $141 |
0%
upside
| 2 | -3.2% |
0
%
| 31 Jul ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $34 |
40%
upside
| 2 | – |
–
| 14 Jul ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $18 |
127%
upside
| 1 | -15% |
0
%
| 30 Jun ‘25 6 months ago |
|
|
|
Neutral
Reiterated
| $130 |
25%
upside
| 1 | – |
–
| 18 Jun ‘25 6 months ago |
|
|
|
Neutral
Reiterated
| $121 |
35%
downside
| 2 | – |
–
| 12 Jun ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $8 |
1%
downside
| 3 | +7.2% |
0
%
| 22 May ‘25 7 months ago |
|